News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News ESC 2020 Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients Shelley Wood September 04, 2020